Protecting Patient Access to Cancer and Complex Therapies Act
This act aims to change how drug costs are calculated for patients, especially those with cancer and complex conditions. It proposes that manufacturers of certain negotiated drugs provide rebates, potentially lowering out-of-pocket costs for patients. These changes are intended to improve access to expensive therapies.
Key points
Manufacturers of selected drugs, including cancer treatments, will be required to provide rebates if their price exceeds a set amount.
Patient co-payments for drugs may be reduced due to new calculation rules.
Rebate funds will be deposited into the federal health insurance trust fund, potentially stabilizing healthcare financing.
Introduced
Citizen Poll